This order directs the MAHA Commission, in coordination with the Secretary of HHS, the Assistant to the President for Science and Technology (APST), and the Special Advisor for AI and Crypto to develop innovative ways to utilize advanced technologies such as AI to unlock improved diagnoses, treatments, cures, and prevention strategies for pediatric cancer. The initial focus will be to identify opportunities to accelerate the progress of AI-driven solutions at the Childhood Cancer Data Initiative (CCDI) and fund research projects at National Cancer Institute-Designated Cancer Centers that utilize and incorporate AI in their research and analysis.
The order calls for increased investment and engagement in pediatric cancer care and research from both the public and private sector. The order requires that the Secretary of HHS and the ASPT ensure that AI innovation is integrated into current work on interoperability.
Unlocking Cures for Pediatric Cancer with Artificial Intelligence (Trump EO Tracker)
Related Content
© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.